René Blom

Sarcoma and Skin Radiation Oncology

Oxidative stress, inflammation, and cancer: How are they linked?

Tumor–stroma co-evolution in prostate cancer progression and metastasis

New Therapeutics to Treat Castrate‐Resistant Prostate Cancer

Unraveling the therapeutic potential of the Hedgehog pathway in cancer

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

New use of metals as nanosized radioenhancers.

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study

Leiomyosarcoma of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 49 Cases